These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3801500)

  • 21. Urinary 1 beta-hydroxyursodeoxycholic acid during ursodeoxycholic acid therapy.
    Yamakawa R; Kimura A; Aoki K; Suzuki M; Mahara R; Tohma M
    J Gastroenterol; 1996 Dec; 31(6):917-8. PubMed ID: 9027662
    [No Abstract]   [Full Text] [Related]  

  • 22. Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis.
    Nakashima T; Sano A; Seto Y; Nakajima T; Shima T; Sakamoto Y; Okuno T; Kashima K; Hasegawa T
    Hepatology; 1990 Feb; 11(2):255-60. PubMed ID: 2307404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
    Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
    Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.
    Crosignani A; Battezzati PM; Setchell KD; Camisasca M; Bertolini E; Roda A; Zuin M; Podda M
    Hepatology; 1991 Feb; 13(2):339-44. PubMed ID: 1671665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria.
    Fedorowski T; Salen G; Tint GS; Mosbach E
    Gastroenterology; 1979 Nov; 77(5):1068-73. PubMed ID: 488633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
    Shimazu K; Kuwabara M; Yoshii M; Kihira K; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
    J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Abnormal bile acid metabolism in patients with ileal disease and ileal resection--effect of oral ursodeoxycholic acid administration].
    Saitoh O; Matsumoto H; Masaki K; Tatsumi A; Ohshiba S; Masamune O
    Nihon Shokakibyo Gakkai Zasshi; 1986 Jan; 83(1):47-55. PubMed ID: 3702130
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
    Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
    Salen G; Shefer S; Tint GS; Nicolau G; Dayal B; Batta AK
    J Clin Invest; 1985 Aug; 76(2):744-51. PubMed ID: 4031069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The profile of bile acids and their sulfate metabolites in human urine and serum.
    Bathena SP; Mukherjee S; Olivera M; Alnouti Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetylglucosaminides. A new type of bile acid conjugate in man.
    Marschall HU; Egestad B; Matern H; Matern S; Sjövall J
    J Biol Chem; 1989 Aug; 264(22):12989-93. PubMed ID: 2753897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
    Batta AK; Salen G; Shefer S; Tint GS; Batta M
    J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical abnormalities in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Berginer V
    Dev Neurosci; 1991; 13(4-5):363-70. PubMed ID: 1817043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differing effect of chenodeoxycholic acid and ursodeoxycholic acid on bile acids in rat colonic wall and contents.
    Kurtz WJ; Guldutuna S; Leuschner U
    Tokai J Exp Clin Med; 1988 Jun; 13(2):91-7. PubMed ID: 3250006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of 13C-labeled chenodeoxycholic, hyodeoxycholic, and ursodeoxycholic acids for the study of bile acid metabolism in liver disease.
    Matern S; Marschall HU; Schill A; Schumacher B; Lehnert W; Sjövall J; Matern H
    Clin Chim Acta; 1991 Nov; 203(1):77-89. PubMed ID: 1769122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.